The global regenerative medicine market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. Cell therapy segment accounted for the largest share in the global regenerative medicine market in 2018 and is expected to continue its dominance throughout the forecast period. Cell therapy segment includes cell-based therapies such as stem cells and mesenchymal stem cells (MSCs). Cell-based therapies are used for various applications such as cardiovascular diseases, neurological disorders, orthopedic disorders, dermatology conditions etc, which are driving this segment’s growth. Tissue engineering segment accounted for the second largest share in 2018 and is expected to grow at a CAGR of 13% during the forecast period due to its use in various applications including wound healing and tissue regeneration. Biomaterials accounted for third largest share in 2018 due to their use in various applications including wound healing and tissue regeneration. Regenerative medicines are used across different application areas such as dermatology conditions, cardiovascular diseases, neurological disorders etc, which are driving this segment’s growth during the forecast period. North America was estimated to account for over 40% of total revenue generated by regenerative medicines globally owing to high prevalence rates of chronic diseases coupled with high healthcare expenditure per capita among other factors; however Asia Pacific region is projected to witness fastest growth rate during 2019-2030 owing mainly due increased awareness about benefits offered by these products coupled with low cost treatments available here compared with other regions like Europe or North America where they have been more expensive treatments available till date.
- Increasing prevalence of chronic diseases such as diabetes mellitus type 2 (DM2) and cancer are driving the demand for regenerative medicines globally which in turn is fueling the growth of this market over the forecast period (2017-2025).
- Regenerative medicines are also gaining traction due to their ability to treat complex diseases that have no cure or treatment options available currently such as Alzheimer's disease (AD), Parkinson's disease (PD), spinal cord injury (SCI) etc, which will further fuel its growth over the forecast period .
Industry Growth Insights published a new data on “Regenerative Medicine Market”. The research report is titled “Regenerative Medicine Market research by Types (Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin), By Applications (Dermatology, Cardiovascular, CNS, Orthopedic, Others), By Players/Companies DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals, Regenerative Medicin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Regenerative Medicine Market Research Report
By Type
Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin
By Application
Dermatology, Cardiovascular, CNS, Orthopedic, Others
By Companies
DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals, Regenerative Medicin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Regenerative Medicine Market Report Segments:
The global Regenerative Medicine market is segmented on the basis of:
Types
Cell Therapy, Tissue Engineering, Biomaterial, Other, Regenerative Medicin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dermatology, Cardiovascular, CNS, Orthopedic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- DePuy Synthes
- Medtronic
- ZimmerBiomet
- Stryker
- Acelity
- MiMedx Group
- Organogenesis
- UniQure
- Cellular Dynamics International
- Osiris Therapeutics
- Vcanbio
- Gamida Cell
- Golden Meditech
- Cytori
- Celgene
- Vericel Corporation
- Guanhao Biotech
- Mesoblast
- Stemcell Technologies
- Bellicum Pharmaceuticals
- Regenerative Medicin
Highlights of The Regenerative Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Therapy
- Tissue Engineering
- Biomaterial
- Other
- Regenerative Medicin
- By Application:
- Dermatology
- Cardiovascular
- CNS
- Orthopedic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Regenerative Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Regenerative medicine is a field of medical science that uses techniques to restore or improve the function of damaged cells, tissues, organs and whole bodies.
Some of the key players operating in the regenerative medicine market are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologies, Bellicum Pharmaceuticals, Regenerative Medicin.
The regenerative medicine market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Regenerative Medicine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Regenerative Medicine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Regenerative Medicine Market - Supply Chain
4.5. Global Regenerative Medicine Market Forecast
4.5.1. Regenerative Medicine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Regenerative Medicine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Regenerative Medicine Market Absolute $ Opportunity
5. Global Regenerative Medicine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Regenerative Medicine Market Size and Volume Forecast by Type
5.3.1. Cell Therapy
5.3.2. Tissue Engineering
5.3.3. Biomaterial
5.3.4. Other
5.3.5. Regenerative Medicin
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Regenerative Medicine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Regenerative Medicine Market Size and Volume Forecast by Application
6.3.1. Dermatology
6.3.2. Cardiovascular
6.3.3. CNS
6.3.4. Orthopedic
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Regenerative Medicine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Regenerative Medicine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Regenerative Medicine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Regenerative Medicine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Regenerative Medicine Demand Share Forecast, 2019-2026
9. North America Regenerative Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Regenerative Medicine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Regenerative Medicine Market Size and Volume Forecast by Application
9.4.1. Dermatology
9.4.2. Cardiovascular
9.4.3. CNS
9.4.4. Orthopedic
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Regenerative Medicine Market Size and Volume Forecast by Type
9.7.1. Cell Therapy
9.7.2. Tissue Engineering
9.7.3. Biomaterial
9.7.4. Other
9.7.5. Regenerative Medicin
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Regenerative Medicine Demand Share Forecast, 2019-2026
10. Latin America Regenerative Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Regenerative Medicine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Regenerative Medicine Market Size and Volume Forecast by Application
10.4.1. Dermatology
10.4.2. Cardiovascular
10.4.3. CNS
10.4.4. Orthopedic
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Regenerative Medicine Market Size and Volume Forecast by Type
10.7.1. Cell Therapy
10.7.2. Tissue Engineering
10.7.3. Biomaterial
10.7.4. Other
10.7.5. Regenerative Medicin
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Regenerative Medicine Demand Share Forecast, 2019-2026
11. Europe Regenerative Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Regenerative Medicine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Regenerative Medicine Market Size and Volume Forecast by Application
11.4.1. Dermatology
11.4.2. Cardiovascular
11.4.3. CNS
11.4.4. Orthopedic
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Regenerative Medicine Market Size and Volume Forecast by Type
11.7.1. Cell Therapy
11.7.2. Tissue Engineering
11.7.3. Biomaterial
11.7.4. Other
11.7.5. Regenerative Medicin
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Regenerative Medicine Demand Share, 2019-2026
12. Asia Pacific Regenerative Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Regenerative Medicine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Regenerative Medicine Market Size and Volume Forecast by Application
12.4.1. Dermatology
12.4.2. Cardiovascular
12.4.3. CNS
12.4.4. Orthopedic
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Regenerative Medicine Market Size and Volume Forecast by Type
12.7.1. Cell Therapy
12.7.2. Tissue Engineering
12.7.3. Biomaterial
12.7.4. Other
12.7.5. Regenerative Medicin
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Regenerative Medicine Demand Share, 2019-2026
13. Middle East & Africa Regenerative Medicine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Regenerative Medicine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Regenerative Medicine Market Size and Volume Forecast by Application
13.4.1. Dermatology
13.4.2. Cardiovascular
13.4.3. CNS
13.4.4. Orthopedic
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Regenerative Medicine Market Size and Volume Forecast by Type
13.7.1. Cell Therapy
13.7.2. Tissue Engineering
13.7.3. Biomaterial
13.7.4. Other
13.7.5. Regenerative Medicin
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Regenerative Medicine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Regenerative Medicine Market: Market Share Analysis
14.2. Regenerative Medicine Distributors and Customers
14.3. Regenerative Medicine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. DePuy Synthes
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ZimmerBiomet
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Stryker
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Acelity
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MiMedx Group
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Organogenesis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. UniQure
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cellular Dynamics International
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Osiris Therapeutics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vcanbio
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Gamida Cell
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Golden Meditech
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Cytori
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Celgene
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Vericel Corporation
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Guanhao Biotech
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Mesoblast
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Stemcell Technologies
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Bellicum Pharmaceuticals
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook